Search form
Home
People
Centers & Portfolios
Knowledge
About
FAQ
HealthPartners Institute
Romosozumab versus Alendronate and fracture risk in women with osteoporosis [editorial]
Editorial Article
Overview
Research
View All
↑
Overview
Link to Article
10.1056/NEJMc1714810
authors
Lewis, J. R.
Schousboe, John T., MD, PhD
Prince, R. L.
publication date
2018
published in
New England Journal of Medicine
Journal
↑
Research
keywords
Drugs and Drug Therapy
Fractures
Osteoporosis
Risk Factors
↑
Additional Document Info
volume
378
issue
2